The exciting news about Edwards Lifesciences Corporation (NYSE: EW) will be shared on Thursday 24th October 2024. Investors and analysts are eagerly waiting to hear about the company's financial performance for the third quarter of 2024. This significant announcement will happen after market close.
It is anticipated by financial experts on Wall Street that the concern is set to announce an estimated $0.64 profit per share for the quarter. Additionally, the firm is expected to disclose a total revenue of $1.52 billion for this period.
The company's full-year performance has been analyzed by wall street analysts, who have shared their projections. According to the analysis, it is expected that the company will generate a total revenue of $6.13 billion. Additionally, the earnings per share for the company are also anticipated to reach profit of $2.59 over the course of the fiscal year.
When examining the corresponding quarter from the previous year, the company's earnings report highlighted a per-share income of $0.59. This results was derived from the company's total revenue, which reached an impressive $1.48 billion during same quarter.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.70 | +6.1% | 1.63 B | +6.7% |
| Q1 2024 | $0.66 | +6.5% | 1.60 B | +9.5% |
| Q4 2023 | $0.64 | 0% | 1.53 B | +13.8% |
| Q3 2023 | $0.59 | -3.3% | 1.48 B | +12.3% |
| Q2 2023 | $0.66 | +4.8% | 1.53 B | +11.4% |
| *Growth on year-over-year basis | ||||
Additionally, The company will host a conference call with investors and analysts on 24th October 2024 at 05:00 PM eastern time to review the Q3 2024 financial results.
Edwards Lifesciences Corporation (EW) experienced a trading range of $69.14 to $70.01, along with a total volume of 3.34 million shares during the day. The stock concluded Tuesday's regular trading session at $69.24, reflecting downfall of 1.16 percent.
